Yi Lin

4 ta ish

Mayo Clinic in Arizona

1. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

   Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25

   Maqola20217 iqtibos

   ABIABI:AkademIndex/2026.other.296878

2. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

   Noopur Raje, Jesús G. Berdeja, Yi Lin +20

   MaqolaOAOchiq kirish20195 iqtibos

   ABIABI:AkademIndex/2026.other.082848

3. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

   Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett +37

   Maqola20174 iqtibos

   ABIABI:AkademIndex/2026.other.296830

4. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

   Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani +33

   Maqola20214 iqtibos

   ABIABI:AkademIndex/2026.other.475845